Hepatic immune-mediatedadverseeffects of immune checkpoint inhibitors: analysis of real-life experience

Introduction and objectives: Immune Checkpoint Inhibitors (ICI) have shifted the paradigm of cancer therapy treatment. Despite their efficacy, ICIs may induce immune-related adverse events (irAE), which can affect various organs, namely the liver. This study intends to perform a comprehensive clinic...

Full description

Bibliographic Details
Main Authors: Joana Alves da Silva, Daniela Falcão, Cláudia Cardoso, Ana Luísa Pires, António Araújo, Fernando Castro-Poças
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S166526812100260X